Annual Drug Patent Expirations for ELCYS
Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
Drug patent litigation for ELCYS.
The generic ingredient in ELCYS is cysteine hydrochloride. One supplier is listed for this compound. Additional details are available on the cysteine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
